Organism: Homo sapiens
Gene: 38797_at
Selected probe(set): 212110_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38797_at (212110_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):4.9975204
Number of Samples:17 / 18

Experimental	Barrett's esophagus study 3
	Esophageal epithelium samples from areas with Barrett's esophagus metaplasia which were recovered by laser capture microdissection.
Control	normal esophageal epithelium sample
	Histologically normal esophageal squamous cell epithelium biopsy samples from patients that were investigated for esophageal pain, but diagnosed as healthy.

Relative Expression (log2-ratio):4.4614277
Number of Samples:4 / 6

Experimental	F. tularensis study 1 (novicida)
	Peripheral blood monocytes infected with the Francisella tularensis subspecies novicida isolate U112 (100 MOI) for 24 hours.
Control	uninfected peripheral blood monocyte sample
	Peripheral blood monocytes uninfected.

Relative Expression (log2-ratio):4.361514
Number of Samples:20 / 18

Experimental	esophageal adenocarcinoma study 1
	Esophageal adenocarcinoma (EAC) samples of affected epithelium recovered by laser capture microdissection technique.
Control	normal esophageal epithelium sample
	Histologically normal esophageal squamous cell epithelium biopsy samples from patients that were investigated for esophageal pain, but diagnosed as healthy.

Relative Expression (log2-ratio):3.8845158
Number of Samples:2 / 64

Experimental	basal cell carcinoma study 2
	Primary tumor tissue from the skin of patients with basal cell carcinoma (BCC).
Control	normal skin tissue
	Normal skin samples from healthy donors.

Relative Expression (log2-ratio):3.761526
Number of Samples:2 / 2

Experimental	T-cell activation study 3
	CD4+ T-cell samples prepared from crude lymphocyte fraction. Cells were activated with anti-CD3/28 beads for 18hrs.
Control	resting CD4 T-lymphocyte (crude fraction) sample
	Resting CD4 T-lymphocytes prepared from crude lymphocyte fraction.

Relative Expression (log2-ratio):-3.6230974
Number of Samples:4 / 2

Experimental	skin squamous cell carcinoma study 6
	Primary tumor tissue from the skin of patients with squamous cell carcinoma (SCC).
Control	basal cell carcinoma study 2
	Primary tumor tissue from the skin of patients with basal cell carcinoma (BCC).

Relative Expression (log2-ratio):3.520607
Number of Samples:7 / 3

Experimental	Langerhans cell histiocytosis study 1
	Langerhans cell histiocytes (LCH) were isolated from LCH lesions of patients undergoing surgery. All patients had single system disease, five patients had bone lesion, one had skin lesion and one had mucosal manifestation. Langerhans cells histiocytes were purified by FACS as CD1a+ / CD270 + population with > 95% purity.
Control	normal plasmocytoid dendritic cell sample
	Normal plasmocytoid dendritic cells were isolated from peripheral blood of healthy adult donors. Plasmocytoid dendritic cells were defined as HLA-DR+ / CD45RAhi / CD11c- / BDCA2+ population.

Relative Expression (log2-ratio):3.4965544
Number of Samples:3 / 4

Experimental	ovulation study 1
	Early secretory phase (ESE) endometrium tissue.
Control	proliferative phase endometrium tissue
	Proliferative phase (PE) endometrium tissue.

Relative Expression (log2-ratio):-3.474244
Number of Samples:2 / 2

Experimental	LPS study 4
	MONO-MAC-6 (MM6) cells were treated with 10 ng/ml lipopolysaccharide (LPS). ATC code:---
Control	mock treated MONO-MAC-6 cell sample
	MONO-MAC-6 (MM6) cells mock treated.

Relative Expression (log2-ratio):-3.456541
Number of Samples:2 / 2

Experimental	LPS study 4 (shRNA contr.)
	MONO-MAC-6 (MM6) cells were transduced with a control shRNA and then treated with 10 ng/ml lipopolysaccharide (LPS). ATC code:---
Control	mock treated / transduced MONO-MAC-6 cell sample
	MONO-MAC-6 (MM6) cells were transduced with a control shRNA and then mock treated.